Rx Labeling Rule Will Be Final Soon; Warnings & Precautions To Be Merged

FDA plans to eliminate the distinction between "Warnings" and "Precautions" as part of its labeling rewrite rule, Office of New Drugs acting Director Sandra Kweder told the Senate Finance Committee Nov. 18